Tongxin International (TXIC) is in the rapidly expanding auto industry and builds the body structures for commercial vehicles in China. It's trading at a P/E of 5 based on 2008 net income and is growing rapidly.
China INSOline (CHIO) is one of the more speculative plays, but it could be very rewarding. It is an online insurance provider that services the Beijing area. It has great profit margins and high returns on equity. Our main issue is that we have been unable to get in touch with the company, despite trying several different phone numbers and emails.
China Power Equipment (CPQQ.OB) is trading at a P/E of about 10, yet it's growing at breakneck rates. Net income over the past year almost tripled. It manufactures alloy transformer cores and alloy electricity transformers that are designed to step down voltages in power plants.
China Baicaotang Medicine (CNBI) is engaged in three segments in Guangxi province: pharmaceutical distribution, retail pharmacy and pharmaceutical manufacturing. It is currently at a P/E of 6, despite solid growth. It just recently engaged Crocker Coulson to conduct its investor relations, a great sign that it will uplist in the future.YaSheng Group (YHGG.PK) has had quite the month. It's up almost 300% since it recently started making filings again with the Securities and Exchange Commission, which it hadn't done in about three years. Rumors are that it's planning on completing all of its late filings and eventually listing on Nasdaq. If that occurs, this $250 million dollar company could easily reach $1 billion. Again this is a more speculative company, so investors should carefully weigh their decision to invest in it. At the time of publication Bradford was long all the companies mentioned. Buckley was long YaSheng, China Baicaotang Medicine, China INSOline, China Yongxin, Sino Agro Foods and Tongxin International. Please note that due to factors including low market capitalization and/or insufficient public float, we consider Sino Agro Foods, China Linen Textile Industry, China Yongxin Pharmaceuticals, China Rutai, China Advanced Construction Materials, Tongxin International, China INSOline, China Power Equipment, China Baicaotang Medicine and YaSheng to be small-cap stocks. You should be aware that such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information, and that postings such as this one can have an effect on their stock prices.